Skip to content

Cannabis: all studies

Page 273 of 287: studies 2,721 to 2,730 of 2,864, newest first. Back to the cannabis overview

Research

The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.

Journal of Psychopharmacology September 1, 2006 Harry Sumnall, Jon C. Cole, Lisa Jerome 117 citations

Previous investigations of the subjective effects of MDMA (material sold as ecstasy) have conducted interviews and surveys of various groups of ecstasy users within particular sub-populations. This study examined subjective drug effects reported by different sub-populations of ecstasy users and explored whether the function or purpose served by using ecstasy influenced the nature of the drug...

Mindfulness meditation and substance use in an incarcerated population.

Psychology of Addictive Behaviors August 28, 2006 Sarah Bowen, Katie Witkiewitz, Tiara M Dillworth et al. 495 citations

Despite the availability of various substance abuse treatments, alcohol and drug misuse and related negative consequences remain prevalent. Vipassana meditation (VM), a Buddhist mindfulness-based practice, provides an alternative for individuals who do not wish to attend or have not succeeded with traditional addiction treatments. In this study, the authors evaluated the effectiveness of a VM...

DOI: 10.1037/0893-164x.20.3.343 (opens in new tab) Addiction Psychosocial Clinical psychology Substance abuse +3

Classification of illegal and harmful drugs

BMJ August 3, 2006 Michael Gossop 8 citations

This week the House of Commons Select Committee on Science and Technology published the report of its inquiry on the classification of illegal drugs in the United Kingdom.1 The report high-lighted glaring anomalies in the classification of illegal drugs into classes A, B, and C and reflected a broad agreement that the current system is not fit for purpose. The committee also reported...

DOI: 10.1136/bmj.38929.578414.80 (opens in new tab) Full text (opens in new tab) Government linguistics House of commons Select committee Advisory committee +7

Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.

Journal of Pharmacology and Experimental Therapeutics July 2006 Sachin Patel, Cecilia J. Hillard

Extracts of Cannabis sativa have been used for their calming and sedative effects for centuries. Recent developments in drug discovery have suggested that modulation of neuronal endogenous cannabinoid signaling systems could represent a novel approach to the treatment of anxiety-related disorders while minimizing the adverse effects of direct acting cannabinoid receptor agonists. In this study,...

Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.

Neuropsychopharmacology July 2006 Michael John Morgan, Lara Chiara Impallomeni, Alessandro Pirona et al.

Ecstasy (MDMA; 3,4-methylenedioxymethamphetamine) has a well-recognized neurotoxic effect on central serotonergic (5-HT) systems in animals, and there is some evidence of persistent serotonergic dysregulation in human ecstasy users. Serotonin is believed to mediate impulsive behavior and effective decision-making. Thus, the aim of the present study was to investigate impulsive behavior and...

Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.

Neuropharmacology June 2006 Evelyne Célérier, Therese Ahdepil, Helena Wikander et al.

The identification of the possible factors that might enhance the risk of developing drug addiction and related motivational disorders is crucial to reduce the prevalence of these problems. Here, we examined in mice whether the exposure to the anabolic-androgenic steroid nandrolone would affect the pharmacological and motivational effects induced by Delta(9)-tetrahydrocannabinol (THC), the...

Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study

Journal of Psychoactive Drugs June 1, 2006 Michael Lerner, Michael Lyvers 99 citations

Psychedelic drugs such as LSD and psilocybin are often claimed to be capable of inducing life-changing experiences described as mystical or transcendental, especially if high doses are taken. The present study examined possible enduring effects of such experiences by comparing users of psychedelic drugs (n = 88), users of nonpsychedelic illegal drugs (e.g., marijuana, amphetamines) (n = 29) and...

Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.

European Journal of Neuroscience May 2006 Anna Lisa Muntoni, Giuliano Pillolla, Miriam Melis et al.

The noradrenergic pathway arising from the locus coeruleus (LC) is involved in the regulation of attention, arousal, cognitive processes and sleep. These physiological activities are affected by Cannabis exposure - both in humans and laboratory animals. In addition, exogenous cannabinoids, as well as pharmacological and genetic manipulation of the endocannabinoid system, are known to influence...

Application of a computational decision model to examine acute drug effects on human risk taking.

Experimental and Clinical Psychopharmacology May 2006 Scott D Lane, Eldad Yechiam, Jerome R. Busemeyer

In 3 previous experiments, high doses of alcohol, marijuana, and alprazolam acutely increased risky decision making by adult humans in a 2-choice (risky vs. nonrisky) laboratory task. In this study, a computational modeling analysis known as the expectancy valence model (J. R. Busemeyer & J. C. Stout, 2002) was applied to individual-participant data from these studies, for the highest...

Diagnosing Depersonalization Disorder

Feeling Nureal April 20, 2006 Daphne Simeon, Jeffrey Abugel

Abstract: Like any other psychiatric condition, the diagnosis of depersonalization disorder (DPD) is made clinically, by meeting with the patient and conducting a thorough evaluation interview. Descriptions of the symptoms, as we have described throughout this book, and as spelled out in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), serve as the point of...